Pure Biologics SA
XMUN:PQB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pure Biologics SA
XMUN:PQB
|
PL |
|
Coretech 5 SA
PAR:MLCOT
|
FR |
|
Eyenovia Inc
NASDAQ:HYPD
|
US |
|
H
|
Hellenic Exchanges Athens Stock Exchange SA
ATHEX:EXAE
|
GR |
|
R
|
Royal Hotel Ltd
TSE:9713
|
JP |
|
E
|
Erin Ventures Inc
XTSX:EV
|
CA |
|
B
|
Boron One Holdings Inc
XTSX:BONE
|
CA |
|
Y
|
YIT Oyj
XMUN:YIT
|
FI |
|
S
|
SEI Medical PCL
SET:SEI
|
TH |
|
T
|
Tethys Petroleum Ltd
OTC:TETHF
|
GG |
|
O
|
Obocon Inc
OTC:OBCN
|
US |
|
E
|
Elio Motors Inc
OTC:ELIO
|
US |
|
N
|
Newmac Resources Inc
XTSX:NER
|
CA |
|
T
|
Taitien Electronics Co Ltd
TPEX:8289
|
TW |
|
C
|
Cardlytics Inc
F:CYX
|
US |
|
C
|
CSR Ltd
SWB:CSR
|
AU |
|
Moonpig Group PLC
F:769
|
UK |
Shareholder Yield
Current shareholder yield for PQB is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
PQB Price
Pure Biologics SA
| Average Annual Return | -26.1% |
| Standard Deviation of Annual Returns | 41.42% |
| Max Drawdown | -98% |
| Market Capitalization | 661.4m EUR |
| Shares Outstanding | 7 095 608 |
| Percentage of Shares Shorted |
N/A
|
